Page 11 - Erytech Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pancreatic Cancer Pipeline is enriched with novel therapeutic strategies, including a broad range of therapies targeting diverse biologic processes. The...

WEST CHESTER, Pa.--(BUSINESS WIRE)--Papyrus Therapeutics Inc. is delighted to announce that two new members have joined our Board of Directors, Marc Beer as chairman and Professor James Lorens PhD as an independent director.Marc brings more then 30 years of therapeutic development and commercialization experience in...

ERYTECH to Participate in Upcoming Virtual Investor Conferences in June Lyon (France) and Cambridge, MA (U.S.), May 26, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced its partipation in the following investor conferences in the month of June. Jefferies Virtual Healthcare Conference – June 1- 4, 2021 Gil Beyen, Chief Executive Officer, will be participating in a fireside chat followed by a virtual Q&A session on...

29.04.2021 - ERYTECH Reports Cash Balance at End of Q1 2021 and Announces the Details of its 2021 Q1 conference call Publication of Q1 2021 results on 4 May 2021 after market close Lyon (France) and Cambridge, MA (U.S.), April 29, 2021 – ERYTECH Pharma ... Seite 1

Acute Lymphocytic Market Size Estimated to Reach $3.23 Billion by 2025 Rise in the Number of Bone Marrow Biopsies and Increase in the Research and Development Activities Is Likely to Aid in the Market Growth of Acute Lymphocytic/lymphoblastic Leukemia Market. BriefingWire.com, 3/17/2021 - Acute Lymphocytic/Lymphoblastic Leukemia Market size is estimated to reach $3.23Bn by 2025, growing at a CAGR of 5.1% during the forecast period 2020-2025. Acute Lymphocytic/Lymphoblastic Leukemia is a type of cancer of blood and bone marrow that affects white blood cells. It ...